Journal of Reproduction & Infertility

Journal of Reproduction & Infertility

Association Between Promoter Polymorphisms of IL-1Β, IL-4 and IL-6 Genes and a Viral Load Infected Women with Human Papillomavirus

Authors
Abbas Albosale 1
Elena Mashkina 2
1 Department of Medical Laboratory Techniques, Al-Dour Technical Institute, Northern Technical University, Saladin, Iraq; Genetics Department of Academy of Biology and Biotechnology, Southern Federal University-Russia, Rostov-on-Don
2 Genetics Department of Academy of Biology and Biotechnology, Southern Federal University-Russia, Rostov-on-Don, Russia
10.18502/jri.v22i2.5794
Abstract
Background: The purpose of this study was to investigate the association between IL-4 -589C>T, IL-6 -174G>C, IL-1β -31T>C and IL-1β -511C>T genes polymorphism with high concentrations of human papillomavirus (HPV), and the influence of gene-gene interactions on persistent human papillomavirus infection. Methods: In this study, 101 infected women with high HPV viral load and 93 healthy women were involved in a case-control study. Genotyping of SNPs for IL-4 -589C>T, IL-6 -174G>C, IL-1β -31T>C and IL-1β -511C>T genes was carried out by allele-specific PCR. Quantitative analysis of HPV-DNA was performed by Amplisens HPV HCR genotype-titer software. Gene-gene interactions were analyzed using multifactor dimensionality reduction (MDR) algorithm. Haplotype interactions were analyzed by HaploView 4.2 tool. Results: The study of single individual SNPs in promoters of IL-4 -589C>T, IL-6-174G>C and IL-1β -31T>C genes did not reveal statistically significant difference in genotypes and allele frequencies among women with high HPV viral load and control group. The frequency of -511T allele and TT genotype of the IL-1β gene in case group was significantly higher than the one in control group (OR=1.71, p=0.012 and OR=2.02, p=0.046, respectively). Haplotype analysis revealed that -511C/-31T haplotype for IL-1β gene is significantly less common among women with high HPV viral load (p=0.018). Conclusion: The haplotype -511C/-31T for IL-1β gene is associated with a protective effect against increasing HPV viral load. The frequencies of -511T allele and -511TT genotype of the IL-1β -511C>T were significantly higher among women with HPV in comparison to control group.
Keywords
Cytokines
Human papillomavirus (HPV)
Inflammation
Polymorphism
Viral load
Zur Hausen H. Papillomaviruses in the causation of human cancers-a brief historical account. Virology. 2009;384(2):260-5.
Choi YJ, Park JS. Clinical significance of human papillomavirus genotyping. J Gynecol Oncol. 2016;27(2):e21.
Gravitt PE, Winer RL. Natural history of HPV infection across the lifespan: role of viral latency. Viruses. 2017;9(10):267.
Song D, Li H, Li H, Dai J. Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer. Oncol Lett. 2015;10(2):600-6.
Wang X, Huang X, Zhang Y. Involvement of human papillomaviruses in cervical cancer. Front Microbiol. 2018;9:2896.
Lin W, Niu Z, Zhang H, Kong Y, Wang Z, Yang X, et al. Imbalance of Th1/Th2 and Th17/Treg during the development of uterine cervical cancer. Int J Clin Exp Pathol. 2019;12(9):3604-12.
Scott ME, Shvetsov YB, Thompson PJ, Hernandez BY, Zhu X, Wilkens LR, et al. Cervical cytokines and clearance of incident human papillomavirus infection: Hawaii HPV cohort study. Int J Cancer. 2013;133(5):1187-96.
Peghini BC, Abdalla DR, Barcelos ACM, Teodoro L das GVL, Murta EFC, et al. Local cytokine profiles of patients with cervical intraepithelial and invasive neoplasia. Hum Immunol. 2012;73(9):920-6.
Setrerrahmane S, Xu H. Tumor-related interleukins: old validated targets for new anti-cancer drug development. Mol Cancer. 2017;16(1):153.
Bais AG, Beckmann I, Lindemans J, Ewing PC, Meijer C, Snijders PJF, et al. A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions. J Clin Pathol. 2005;58(10):1096-100.
Georgescu SR, Mitran CI, Mitran MI, Caruntu C, Sarbu MI, Matei C, et al. New insights in the pathogenesis of HPV infection and the associated carcinogenic processes: the role of chronic inflammation and oxidative stress. J Immunol Res. 2018;2018:5315816.
Heeb LEM, Egholm C, Boyman O. Evolution and function of interleukin-4 receptor signaling in adaptive immunity and neutrophils. Genes Immun. 2020;21(3):143-9.
Choy E, Rose-John S. Interleukin-6 as a multifunctional regulator: inflammation, immune response, and fibrosis. J Scleroderma Relat Disord. 2017;2(2_suppl):S1-5.
Wei LH, Kuo ML, Chen CA, Chou CH, Lai KB, Lee CN, et al. Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene. 2003;22(10):1517-27.
Kaneko N, Kurata M, Yamamoto T, Morikawa S, Masumoto J. The role of interleukin-1 in general pathology. Inflamm Regen. 2019;39:12.
Guo Y, Jamison DC. The distribution of SNPs in human gene regulatory regions. BMC Genomics. 2005;6:140.
Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, Marth G, et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature. 2001;409(6822):928-33.
Takabayashi A, Ihara K, Sasaki Y, Kusuhara K, Nishima S, Hara T. Novel polymorphism in the 5′-untranslated region of the interleukin-4 gene. J Hum Genet. 1999;44(5):352-3.
Vickers MA, Green FR, Terry C, Mayosi BM, Julier C, Lathrop M, et al. Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res. 2002;53(4):1029-34.
Hall SK, Perregaux DG, Gabel CA, Woodworth T, Durham LK, Huizinga TWF, et al. Correlation of polymorphic variation in the promoter region of the interleukin‐1β gene with secretion of interleukin‐1β protein. Arthritis Rheum. 2004;50(6):1976-83.
Federal Budget Institute of Science. Central research institute for epidemiology. DNA-sorb-AM nucleic acid extraction kit instruction manual. Moscow, Russia. Available from: https://interlabservice.ru/upload/iblock/bb8/DNA-sorb-AM%20060318.pdf
Federal Budget Institute of Science. Central research institute for epidemiology. AmpliSens HPV HCR screen-titre-FRT PCR kit instruction manual. Moscow, Russia. Available from: https://interlabservice.ru/upload/iblock/614/HPV%20HCR%20screen-titre-FRT%20261118.pdf.
Federal Budget Institute of Science. Central research institute for epidemiology. AmpliSens HPV HCR genotype-titre-FRT PCR kit instruction manual. Moscow, Russia. Available from: https://interlabservice.ru/upload/iblock/2f9/HPV%20HCR%20genotype-titre-FRT_ME_140918.pdf.
Hahn LW, Ritchie MD, Moore JH. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics. 2003;19(3):376-82.
Radley D, Saah A, Stanley M. Persistent infection with human papillomavirus 16 or 18 is strongly linked with high-grade cervical disease. Hum Vaccin Immunother. 2016;12(3):768-72.
Akram Husain RS, Ramakrishnan V. A review of risk factors in the development of cervical malignancy. Cancer Sci Res Open Access. 2016;3(1):1-4.
Trottier H, Ferreira S, Thomann P, Costa MC, Sobrinho JS, Prado JCM, et al. Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunity. Cancer Res. 2010;70(21):8569-77.
Au WW, Abdou-Salama S, Sierra-Torres CH, Al-Hendy A. Environmental risk factors for prevention and molecular intervention of cervical cancer. Int J Hyg Environ Health. 2007;210(6):671-8.
Landskron G, De la Fuente M, Thuwajit P, Thuwajit C, Hermoso MA. Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res. 2014;2014:149185.
Chakraborty C, Sharma AR, Sharma G, Lee SS. The interplay among miRNAs, major cytokines, and cancer-related inflammation. Mol Ther Nucleic Acids. 2020;20:606-20.
Li Z, Chen L, Qin Z. Paradoxical roles of IL-4 in tumor immunity. Cell Mol Immunol. 2009;6(6):415-22.
Bankaitis KV, Fingleton B. Targeting IL4/IL4R for the treatment of epithelial cancer metastasis. Clin Exp Metastasis. 2015;32(8):847-56.
Kim BS, Park SM, Uhm TG, Kang JH, Park JS, Jang AS, et al. Effect of single nucleotide polymorphisms within the interleukin-4 promoter on aspirin intolerance in asthmatics and interleukin-4 promoter activity. Pharmacogenet Genomics. 2010;20(12):748-58.
Venmar KT, Carter KJ, Hwang DG, Dozier EA, Fingleton B. IL4 receptor ILR4α regulates metastatic colonization by mammary tumors through multiple signaling pathways. Cancer Res. 2014;74(16):4329-40.
Lippitz BE, Harris RA. Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosis. Oncoimmunology. 2016;5(5):e1093722.
De lima Júnior SF, Tavares MMF, Macedo JL de, Oliveira RS de, Heráclio S de A, Maia M de MD, et al. Influence of IL-6, IL-8, and TGF-β1 gene polymorphisms on the risk of human papillomavirus-infection in women from Pernambuco, Brazil. Mem Inst Oswaldo Cruz. 2016;111(11):663-9.
Gangwar R, Mittal B, Mittal RD. Association of interleukin-6–174G> C promoter polymorphism with risk of cervical cancer. Int J Biol Markers. 2009;24(1):11-6.
Pu X, Gu Z, Wang X. Polymorphisms of the interleukin 6 gene and additional gene–gene interaction contribute to cervical cancer susceptibility in Eastern Chinese women. Arch Gynecol Obstet. 2016;294(6):1305-10.
Sobti RC, Tamandani DMK, Shekari M, Kaur P, Malekzadeh K, Suri V. Interleukin 1 beta gene polymorphism and risk of cervical cancer. Int J Gynecol Obstet. 2008;101(1):47-52.
Simonart T, Van Vooren JP. Interleukin-1β increases the Bcl-2/Bax ratio in Kaposi’s sarcoma cells. Cytokine. 2002;19(6):259-66.
Qian N, Chen X, Han S, Qiang F, Jin G, Zhou X, et al. Circulating IL-1β levels, polymorphisms of IL-1B, and risk of cervical cancer in Chinese women. J Cancer Res Clin Oncol. 2010;136(5):709-16.
Al-Tahhan MA, Etewa RL, El Behery MM. Association between circulating interleukin-1 beta (IL-1β) levels and IL-1β C-511T polymorphism with cervical cancer risk in Egyptian women. Mol Cell Biochem. 2011;353(1-2):159-65.
Gupta MK, Singh R, Banerjee M. Cytokine gene polymorphisms and their association with cervical cancer: a north Indian study. Egypt J Med Hum Genet. 2016;17(2):155-63.
Journal of Reproduction & Infertility
Volume 22, Issue 2
Spring 2021
Pages 92-102